APAna Sol Peinetti

Ana Sol Peinetti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ana Sol Peinetti has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In vitro evolution of DNA operators enables multivalency protein−DNA interactions: towards programmable transcription factor regulation

    by Natalia S. Adler, Giuliano T. Antelo, Matías Villarruel Dujovne, Johnma J. Rondón, My Tra Le, David P. Giedroc, Ana Sol Peinetti, Daiana A. Capdevila

    In vitro transcription (IVT) systems regulated by allosteric transcription factors (aTFs) are central to emerging cell-free biosensing and synthetic biology platforms, yet their performance is often limited by suboptimal protein–DNA interactions and the need for well-characterized regulatory elements. Here, we report an in vitro evolution strategy to engineer DNA operator sequences that enables tunable aTF–DNA interactions without requiring prior detailed knowledge of the native operator or regulatory mechanism. Using a SELEX-based approach with integrated positive and counter-selection steps, we evolved non-natural operators for the sulfane sulfur–responsive transcriptional repressor SqrR. The selected sequences preserve ligand-responsive allostery, with some sequences exhibiting enhanced binding affinity and reducing transcriptional leakage. Notably, we identify operator with binding behaviors consistent with cooperative recruitment of multiple SqrR dimers, suggesting that sequence architecture can modulate aTF–DNA interactions beyond affinity alone. Incorporation of these operators into IVT circuits improves transcriptional control and dynamic range, enabling the development of ROSALIND-based sensors for sulfane sulfur species, achieving sensitive and selective detection in a fully cell-free format. More broadly, this work establishes operator evolution as a programmable strategy to optimize transcription factor–DNA interactions and expand the design space of transcription-based biosensors, including for systems lacking well-characterized genetic components.

  • Single nanochannel-based iontronic detection of adenosine

    by L. Miguel Hernández Parra, Marcos E. Gramajo, Lautaro Otero Maffoni, Gregorio Laucirica, Ana S. Peinetti, M. Lorena Cortez, M. Eugenia Toimil-Molares, Waldemar A. Marmisollé, Omar Azzaroni


  • Lateral flow cell-free transcriptional assay for contaminant detection

    by Matias Villarruel Dujovne, Carolina Silva, Fatima Alvarez Rocco, Gustavo Ghiglieri, Mariana Riesgo, Daiana Andrea Capdevila, Ana Sol Peinetti


  • Open Access

    Lateral flow cell-free transcriptional assay for contaminant detection

    by Matias Villarruel Dujovne, Carolina Silva, Fatima Alvarez Rocco, Gustavo Ghiglieri, Mariana Riesgo, Daiana A. Capdevila, Ana Sol Peinetti

    Cell free transcriptional biosensors are emerging as a powerful technology, offering enhanced capabilities for detecting chemical contaminants in settings where traditional analytical techniques fall short of societal needs. However, the sensitivity of these biosensors for many critical chemical contaminants often remains insufficient to meet regulatory detection limits, while maintaining portability and ensuring selectivity. In this work, an in vitro transcription (IVT) based lateral flow assay (LFA) is reported, which is 1000 times more sensitive than reported IVT portable detection methods. Through combining the amplification power of IVT with nucleic acid LFA-based avidity effects, we develop rapid, ultra-sensitive turn-on sensors. Our sensors meet regulatory detection limits for lead, a particularly challenging metal ion contaminant, in untreated spring water samples collected from a basin that exemplifies the environmental monitoring challenges. Additionally, we show that by optimizing the IVT conditions, we can tune the limit of detection to produce an on-off signal reaching the WHO regulation threshold and others. Finally, we evaluate the selectivity of different metal-responsive repressors in the context of in vitro biosensing and discuss how to identify potentially hazardous samples with an easy-to-use and point-of-care assay.

  • Nucleic Acids Production

    by Natalia Sol Adler, Ana Sol Peinetti

  • Harnessing concerted functions in confined environments: cascading enzymatic reactions in nanofluidic biosensors for sensitive detection of arginine

    by Marcos E. Gramajo, Lautaro Otero Maffoni, L. Miguel Hernández Parra, Waldemar A. Marmisollé, M. Lorena Cortez, M. Eugenia Toimil-Molares, Ana S. Peinetti, Omar Azzaroni

    Cascading enzymatic reactions within nanochannels enable rapid (<5 min) and highly sensitive detection of arginine by leveraging cooperative functions in a confined environment.


  • Open Access

    Overcoming Limited Access to Virus Infection Rapid Testing: Development of a Lateral Flow Test for SARS-CoV-2 with Locally Available Resources

    by Estefanía S. Peri Ibáñez, Agostina Mazzeo, Carolina Silva, Maria Juliana Juncos, Guadalupe S. Costa Navarro, Horacio M. Pallarés, Virginia J. Wolos, Gabriel L. Fiszman, Silvia L. Mundo, Julio J. Caramelo, et al.

    The COVID-19 pandemic highlighted testing inequities in developing countries. Lack of lateral flow test (LFT) manufacturing capacity was a major COVID-19 response bottleneck in low- and middle-income regions. Here we report the development of an open-access LFT for SARS-CoV-2 detection comparable to commercial tests that requires only locally available supplies. The main critical resource is a locally developed horse polyclonal antibody (pAb) whose sensitivity and selectivity are greatly enhanced by affinity purification. We demonstrate that these Abs can perform similarly to commercial monoclonal antibodies (mAbs), as well as mAbs and other pAbs developed against the same antigen. We report a workflow for test optimization using nasopharyngeal swabs collected for RT-qPCR, spiked with the inactivated virus to determine analytical performance characteristics as the limit of detection, among others. Our final prototype showed a performance similar to available tests (sensitivity of 83.3% compared to RT-qPCR, and 90.9% compared to commercial antigen tests). Finally, we discuss the possibility and the challenges of utilizing affinity-purified pAbs as an alternative for the local development of antigen tests in an outbreak context and as a tool to address inequalities in access to rapid tests.


  • Binding Affinity Measurements Between DNA Aptamers and their Virus Targets Using ELONA and MST

    by Gregory T. Pawel, Yuan Ma, Yuting Wu, Yi Lu, Ana Sol Peinetti

    Aptamers have been selected with strong affinity and high selectivity for a wide range of targets, as recently highlighted by the development of aptamer-based sensors that can differentiate infectious from non-infectious viruses, including human adenovirus and SARS-CoV-2. Accurate determination of the binding affinity between the DNA aptamers and their viral targets is the first step to understanding the molecular recognition of viral particles and the potential uses of aptamers in various diagnostics and therapeutic applications. Here, we describe protocols to obtain the binding curve of the DNA aptamers to SARS-CoV-2 using Enzyme-Linked Oligonucleotide Assay (ELONA) and MicroScale Thermophoresis (MST). These methods allow for the determination of the binding affinity of the aptamer to the infectious SARS-CoV-2 and the selectivity of this aptamer against the same SARS-CoV-2 that has been rendered non-infectious by UV inactivation, and other viruses. Compared to other techniques like Electrophoretic Mobility Shift Assay (EMSA), Surface Plasmon Resonance (SPR), and Isothermal Titration Calorimetry (ITC), these methods have advantages for working with larger particles like viruses and with samples that require biosafety level 2 facilities.


  • In vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

    by Marcos Ezequiel Gramajo, Ryan J. Lake, Yi Lu, Ana Sol Peinetti

    Virus infections have a major impact on society; most methods of detection have difficulties in determining whether a detected virus is infectious, causing delays in treatment and further spread of the virus. Developing new sensors that can inform on the infectability of clinical or environmental samples will meet this unmet challenge. However, very few methods can obtain sensing molecules that can recognize an intact infectious virus and differentiate it from the same virus that has been rendered non-infectious by disinfection methods. Here, we describe a protocol to select aptamers that can distinguish infectious viruses vs non-infectious viruses using systematic evolution of ligands by exponential enrichment (SELEX). We take advantage of two features of SELEX. First, SELEX can be tailor-made to remove competing targets, such as non-infectious viruses or other similar viruses, using counter selection. Additionally, the whole virus can be used as the target for SELEX, instead of, for example, a viral surface protein. Whole virus SELEX allows for the selection of aptamers that bind specifically to the native state of the virus, without the need to disrupt of the virus. This method thus allows recognition agents to be obtained based on functional differences in the surface of pathogens, which do not need to be known in advance.


  • Label-Free Digital Detection of Intact Virions by Enhanced Scattering Microscopy

    by Nantao Li, Xiaojing Wang, Joseph Tibbs, Congnyu Che, Ana Sol Peinetti, Bin Zhao, Leyang Liu, Priyash Barya, Laura Cooper, Lijun Rong, et al.

    Several applications in health diagnostics, food, safety, and environmental monitoring require rapid, simple, selective, and quantitatively accurate viral load monitoring. Here, we introduce the first label-free biosensing method that rapidly detects and quantifies intact virus in human saliva with single-virion resolution. Using pseudotype SARS-CoV-2 as a representative target, we immobilize aptamers with the ability to differentiate active from inactive virions on a photonic crystal, where the virions are captured through affinity with the spike protein displayed on the outer surface. Once captured, the intrinsic scattering of the virions is amplified and detected through interferometric imaging. Our approach analyzes the motion trajectory of each captured virion, enabling highly selective recognition against nontarget virions, while providing a limit of detection of 1 × 103 copies/mL at room temperature. The approach offers an alternative to enzymatic amplification assays for point-of-collection diagnostics.